Company intelligence / Profile preview

Percorso Life Sciences

Wayne, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Percorso Life Sciences was a business process outsourcing and logistics company providing critical support services, including logistics, sales, and customer service, to life science manufacturers, primarily assisting European and Asian companies with U.S. market expansion. Acquired by Parel Bio on November 6, 2024, the company was known for its rapid delivery capabilities and ISO 9001:2015 certification, operating under client brands to preserve their market identity.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Percorso Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Percorso Life Sciences.

Explore the full profile